This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 (VISN 15) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the rental extension of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers. The contract is a firm...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, with a ceiling value of $49,748.73, is for the rental of Novocure's Optune Plus transducers, a proprietary cancer therapy system that delivers alternating electric fields to disrupt solid tumor cancer cell division. The contract is a Delivery Order issued under Novocure's 5-year Federal...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is part of Novocure's Federal Supply Schedule...
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the delivery of Optune Plus transducers, a component of Novocure's Tumor Treating Fields (TTFields) therapy devices used to treat glioblastoma and mesothelioma. The contract is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS)...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, with a ceiling value of $49,748.73, is for the provision of Optune Plus Transducers, a proprietary medical device system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is a delivery order under...
This is a $49,748.73 firm fixed-price federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The award is structured as a purchase order under Novocure's existing 5-year, $28.85...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award is a delivery order issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, with a ceiling value of $49,748.73, is for the rental of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is issued under Novocure's existing 5-year...
This is a $49,748.73 firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services for the treatment of glioblastoma and mesothelioma at VA medical facilities. The...